Hybrids Blurring Regulatory Lines

Derek discusses hybrid AI tools sold as business solutions that claim clinical benefits and may evade FDA oversight.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!